Workflow
CARE
icon
Search documents
'Why the hell did you vote for the bill?': GOP senator slammed for megabill whiplash
MSNBC· 2025-07-02 01:10
Good evening from New York. I'm Chris Hayes. You know, there's a meme I see on the internet all the time.You might have seen it, too. It is a post by the satirical social media outfit cousin of the Onion called Click Hole. And it's a photo of this very seriousl looking man with the headline, "Hartbreaking. The worst person you know just made a great point on social media. This can indeed be heartbreaking. It could be heartbreaking in real life." And that post has taken on a life of its own over the last few ...
X @Forbes
Forbes· 2025-07-02 00:20
Explore how proximity bias limits career growth in remote and hybrid workplaces, as leadership habits prioritize visibility over performance and inclusion declines. https://t.co/DGBypFCvrY https://t.co/DGBypFCvrY ...
DOGE’D!? Demoted Musk threatened with humiliating cuts by his OWN DOGE ‘monster’ over budget 
MSNBC· 2025-07-02 00:08
>> WE'RE REPORTING. >> ON THIS BREAKING NEWS. >> OUT OF WASHINGTON.>> THE SENATE HAS PASSED THE TRUMP. >> BUDGET TODAY. AFTER A BRUISING.>> BATTLE THAT DID. >> LOSE SEVERAL. >> REPUBLICAN VOTES.IT REQUIRED. >> THE. TRUMP WHITE.>> HOUSE. >> TO SEND DOWN VICE. >> PRESIDENT VANCE.TO CAST THIS TIE BREAKING VOTE AND SAVE THE EMBATTLED BILL. ON THIS. >> VOTE.>> THE YEAS. >> ARE 50. >> THE NAYS ARE 50. >> THE SENATE.>> BEING EVENLY. >> DIVIDED. >> THE VICE.>> PRESIDENT VOTES IN THE AFFIRMATIVE. >> THE BILL. >> AS. ...
X @Forbes
Forbes· 2025-07-01 23:20
The smartest career bet isn't avoiding AI—it's learning to direct it. https://t.co/QSuUaNQVWl https://t.co/VtePlEMCG3 ...
X @Bloomberg
Bloomberg· 2025-07-01 21:12
Centene shares plunged after the health insurer pulled its 2025 guidance following an early analysis of data from the Affordable Care Act marketplace that showed a significant revenue hit from a risk-sharing mechanism https://t.co/UAPgTjrHd4 ...
WeightWatchers and Novo Nordisk Expand Collaboration to Improve Medication Access Through Trusted, Holistic Model of Care
Globenewswire· 2025-07-01 20:44
Core Insights - WeightWatchers has expanded its collaboration with Novo Nordisk to provide members with access to FDA-approved Wegovy® at a reduced price of $299, effective July 1, 2025, offering a $200 savings [1][3] - The partnership aims to enhance patient outcomes through a holistic model that combines medication access with WeightWatchers' nutrition and behavioral support programs [4][7] - Wegovy® is the only FDA-approved semaglutide treatment for weight loss, currently supporting nearly 1.5 million patients in the U.S., and has been shown to deliver significant weight loss results when combined with WeightWatchers' support [5][7] Company Overview - WeightWatchers is recognized as a global leader in science-backed weight management, focusing on long-term weight health and prescribing only FDA-approved medications [1][8] - The company emphasizes a holistic approach that integrates clinical interventions, community support, and a trusted weight-loss program [8] Collaboration Details - The collaboration includes a simplified prescription process through NovoCare® Pharmacy, which will facilitate home delivery of Wegovy® prescriptions for WeightWatchers Clinic members [2] - WeightWatchers and Novo Nordisk plan to explore real-world research initiatives to evaluate the impact of combining Wegovy® with WeightWatchers' support programs on long-term health outcomes [4][5] Market Position - WeightWatchers positions itself as a trusted leader in a market filled with unapproved and unsafe weight management options, focusing on evidence-based care and patient safety [4][5] - The company aims to set the standard for responsible weight management by combining access to safe medications with comprehensive lifestyle support [4]
Meiwu Technology Company Limited and Shenzhen Zhinuo Weichuang Technology Co., Ltd Form Strategic Partnership
Globenewswire· 2025-07-01 20:15
Core Viewpoint - Meiwu Technology Company Limited has entered into an agreement with Shenzhen Zhinuo Weichuang Technology Co., Ltd. to enhance its brand influence and market competitiveness [1][2]. Group 1: Agreement Details - The agreement with Zhinuo Weichuang is for a term from July 1, 2025, to June 30, 2026, focusing on comprehensive marketing services [2]. - The service fee structure includes a fixed upfront fee of RMB 1,000,000 and a monthly service fee of RMB 200,000 [4]. Group 2: Services Provided - Zhinuo Weichuang will provide services such as market research, strategic planning, ongoing operational services, and data analysis [4]. - The company will also assist in API connections and data interface development, along with a performance-based fee structure linked to conversion results on major e-commerce platforms [4]. Group 3: Company Background - Meiwu Technology Company Limited, incorporated in the British Virgin Islands, transitioned its business from online sales of food products to the skincare industry [5]. - The company currently sells functional skincare products through its subsidiary, Xiamen Chunshang Health Technology Co., Ltd. [5].
X @Forbes
Forbes· 2025-07-01 20:10
How To Successfully Navigate The Three Stages Of Your Career https://t.co/2OMvtI8Iys https://t.co/2OMvtI8Iys ...
Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025
Globenewswire· 2025-07-01 20:05
SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2025 on Thursday, July 31, 2025, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: •Location:https://investor.resmed.com •Date:Thursday, ...
Senate narrowly passes Trump's 'big beautiful bill' after marathon overnight vote
NBC News· 2025-07-01 18:09
Senators just voted to pass the so-called big beautiful bill. On this vote, the yays are 50, the naysay are 50. The Senate being evenly divided, the vice president votes in the affirmative.The bill as amended is passed. This is really the bulk of President Donald Trump's secondterm domestic agenda. It's here in this bill.We're talking, you know, Medicaid cuts, uh, rural clinics and hospital care. This is, you know, there's been a lot of political capital on the line to get this pushed. ...